36
Vol. 66, No. 2 2015
Northeast Florida Medicine
Pediatric Oncology
22. Popovtzer A, Shpitzer T, Bahar G, “et al”. Thyroid cancer in
children: Management and outcome experience of a referral
center.
Otolaryn Head Neck Surg.
2006;135:581-584.
23. Okada T, Sasaki F, Takahashi H, “et al”. Manage-
ment of childhood and adolescent thyroid carcinoma:
Long-term follow-up and clinical characteristics.
Eur J
Pediatr Surg.
2006;16:8-13.
24. Newman KD, Black T, Heller G, “et al”. Differentiated
thyroid cancer: Determinants of disease progression
in patients < 2 years of age at diagnosis.
Ann Surg.
1998;227:33-541.
25. Motazedian M, Shafiei B, Vatankhah P, “et al”. Dif-
ferentiated thyroid carcinoma: comparison of histo-
pathologic characteristics, clinical course, and outcome
between young children and adolescents.
Med Oncol.
2013;30:506-510.
26. Segal K, Shvero J, Stern Y, “et al”. Surgery of thyroid cancer
in children and adolescents.
Head Neck.
1998;20:293-297.
27. Savio R, Gosnell J, Palazzo FF, “et al”. The role of a
more extensive surgical approach in the initial multi-
modality management of papillary thyroid cancer in
children.
J Ped Surg.
2005;40:1696-1700.
28. Gimm O, Rath FW, Dralle H. Pattern of lymph node
metastases in papillary thyroid carcinoma.
Br J Surg.
1998;85:252-254.
29. Massimino M, Collini P, Fagundes L, “et al”. Conserva-
tive surgical approach for thyroid and lymp-node involve-
ment in papillary thyroid carcinoma of childhood and
adolescence.
Pediatr Blood Cancer.
2006;46:307-313.
30. Kowalski LP, Goncalves J, Pinto CA, “et al”. Long-term
survival rates in young patients with thyroid carcinoma.
Arch Otolaryngol Head Neck Surg.
2003;129:746-749.
31. van Santen, HM, Aronson DC, Vulsma T, “et al”. Fre-
quent adverse evants after treatment for childhood-on-
set differentiated thyroid carcinoma: a single institute
experience.
Eur J Carc.
2004;40:1743-1751.
32. Hay ID, Gonzalez-Losada T, Reinalda MS, “et al”.
Long-term outcome in 215 children and adolescents
with papillary thyroid cancer treated during 1940
through 2008.
World J Surg.
2010;34:1192-1202.
33. Hallwirth U, Flores J, Kaserer K, “et al”. Differentiated
thyroid cancer in children and adolescents: the impor-
tance of adequate surgery and review of literature.
Eur
J Pediatr Surg.
1999;9:359-363.
34. Smith MB, Xue H, Takahashi H, “et al”. Iodine 131
thyrod ablation in female children and adolescents:
Long-term risk of infertility and birth defects.
Ann Surg
Oncol.
1994;1:128-131.
35. Yeh SDJ, La Quaglia MP. 131I therapy for pediatric
thyroid cancer.
J Ped Surg.
1997;6:128-133.
36. Kumagai A, Reiners C, Drozd V, “et al”. Childhood
thyroid cancers and radioactive iodine therapy: Neces-
sity of precautious radiation health risk management.
Enodcrine Journal.
2007;54(6):839-847.
37. Pawalczak M, David R, Franklin B, “et al”. Outcomes
of children and adolescents with well-differentiated
thyroid carcinoma and pulmonary metastases follow-
ing 131I treatment: A systematic review.
Thyroid
2010;20:1095-1101.
38. Gao YC, Lu HK. Outcome after high-dose radioiodine
therapy for advanced differentiated thyroid carcinoma
in childhood.
Endocr Res.
2009;34:121-129.
39. Chow SM, Law SCK, Mendenhall WM, “et al”. Dif-
ferentiated thyroid carcinoma in childhood and adoles-
cence – clinical course and role of radioiodine.
Pediatr
Blood Cancer.
2004;42:176-183.
40. Rosario PWS, Maia FFR, Cardoso LD, “et al”. Cor-
relation between cervical uptake and results of post-
surgical radioiodine ablation in patients with thyroid
carcinoma.
Clin Nucl Med.
2004;29:358-361.
41. Bal CS, Kumar A, Pant GS. Radioiodine dose for
remnant ablation in differentiated thyroid carcinoma:
A randomized clinical trial in 509 patients.
J Clin
Endocrinol Metab.
2004;89:1666-1673.
42. Powers PA, Dinauer CA, Tuttle RM, “et al”. Tumor
size and extent of disease at diagnosis predict the
response to initial therapy for papillary thyroid carcino-
ma in children and adolescents.
J Pedr Endocr Metab.
2003;16:693-702.
43. La Quaglia MP, Black T, Holcomb GW, “et al”. Differ-
entiated thyroid cancer: Clinical characteristics, treat-
ment, and outcome in patients under 21 years of age
who present with distant metastases. A report from the
surgical discipline committee of the children’s cancer
group.
J Ped Surg.
2000;35(6):955-960.
44. Reiners C, Biko J, Haenscheid H, “et al”. Twenty-five
years after Chernobyl: Outcome of radioiodine treat-
ment in children and adolescents with very high-risk
radiation-induced differentiated thyroid carcinoma.
J
Clin Endocrinol Metab.
2013;98(7):3039-3048.
45. Rachmiel M, Charron M, Gupta A, “et al”. Evi-
dence-based review of treatment and follow-up of
pediatric patients with differentiated thyroid carcinoma.
J Ped Endocr Metab.
2006;19:1377-1393.
46. Sheper K, Alhefdhi A, Lai N, “et al”. Hereditary medullary
thyroid cancer: Age-appropriate thyroidectomy improves
disease-free survival.
Ann Surg Oncol.
2013;2:1451-1455.
